Matwings Technology is an artificial intelligence company specializing in the life sciences. The company is committed to integrating computational design, wet-lab validation, process scale-up and commercial application into a seamless research and development pipeline. We provide end-to-end AI solutions across research and development, pilot testing, manufacturing, and quality control for industries such as biopharmaceuticals and biomanufacturing. Our proprietary dry-wet closed-loop protein R&D platform, MatwingsVenus™, empowers researchers and biotech enterprises to boost R&D efficiency and accelerate the transition of innovative designs to full-scale production.
Matwings has been successively honored with multiple titles, including the National High-Tech Enterprise, Shanghai Specialized, Refined, Unique and Innovative SME, and Emerging Enterprise in Minhang District. It has also received awards such as the National First Prize in the "Maker in China" AIGC Special Competition, the National Second Prize in the "Maker in China" Enterprise Category, inclusion in the Ministry of Industry and Information Technology's first batch of typical AI application cases in biomanufacturing, and the Bronze Award in the Fifth "Shanghai Talents Global Innovation & Entrepreneurship Competition." To date, Matwings Technology has completed multiple funding rounds backed by prominent investment firms, including SSCILF, SDIC Fund Management, CNPC Kunlun Capital, Qiming Venture Partners, Yonghua Capital, Shanghai Engine Fund, 3E Bioventures Capital, and GSR United Capital.
.png)
Featured in key news report on CCTV Network News
Prof. Hong Liang, Chief Scientist of Matwings Technology, named on the list of 2025 Forbes China New Era Disruptive Founders
Listed in 2025 China AI+ Application Top 50 Excellent Cases
Won the 2025 Supplier of the Year at BIOCHINA Awards
Named in Science AI Leading Enterprises Top 10
Listed in the First Forbes China Investment-worthy Startups 100
Received the 2025 SJTU Fundation Excellent Growth Award
Mr. Liu Hao, CTO, named on the list of Under 30+ Entrepreneurial Pioneers (cyzone 2025)
Shortlisted for the TOP 30 of the SAIL Award at the 2025 World Artificial Intelligence Conference
Selected as a Typical Application Case of AI in Bio-Manufacturing by MIIT
Awarded 2025 EY-Fudan Most Potential Enterprise
Mr. Liu Hao, CTO, honored as Youth Pioneer at the Seeking the Voice of Youth of the 2025 Pujiang Innovation Forum
Selected as an Excellent Case of Achievement Transformation at the 2025 China Bio-Manufacturing Innovation Forum
Listed in the 2025 Chinese Healthcare Front-Runners 100
Won the Bronze Award in the 5th Shanghai Global Talents Innovation & Entrepreneurship Competition
Listed in the Top 100 High-Quality Suppliers of Chinese Pharmaceutical Industry in the 14th Five-Year Plan by Healthcare Executive
Received the Phoenix Award・Annual Bio-Manufacturing Industry Partner at the 2025 China Bio-Manufacturing Awards by VCBeat
Named in the 2025 REAL 100 Innovators in the AI+ Application by JIEMIAN
Named among Pioneer to the Star 2025 China Excellent Sci-Tech Innovation Companies by Cailian Press
Mr. Liu Hao, CTO, awarded Excellent Entrepreneur of Minhang District, Shanghai, China
Selected in the Synbio China & BioMade China 2024 New Infrastructure Brand List
Mr. Liu Hao, CTO, selected in the 5th Shanghai Y50 Forum for Innovation and Entrepreneurship
Won the National First Prize in the Maker in China AIGC Special Competition by MIIT
Awarded the title of Shanghai Specialized, Refined, Unique and Innovative SME
Selected as a 2024 Future Star Enterprise by Shanghai Jiao Tong University
Completed Series A financing with investments from Qiming Venture Partners, Yonghua Capital, Jingtao Capital, and 3E Bioventures Capital
Won the Second Prize in the Enterprise Group at the 9th Maker in China National Finals
Listed in the 2024 Hard & Core Technology Innovators Top 50
Named in Science AI Leading Enterprises Top 10
Awarded the title of Shanghai Sci-Tech SME
Awarded the title of National High-Tech Enterprise
Completed Pre-Series A Founding with investments from GSR United Capital, 3E Bioventures Capital, and Morning Spring Venture Capital
Awarded the title of Newly-rising Enterprise in Sci-Tech Entrepreneurship of Minhang District, Shanghai, China
Received the Hard Core Sci-Tech Innovation Award of Wujing Town, Minhang District, Shanghai, China
Completed Seed Founding with investments from Glory Ventures Capital, Xiaomiao Langcheng Capital
Selected as a Sci-Tech SME and Innovative SME
Won the Winner Award at the 1st Minhang District Overseas Talents Innovation & Entrepreneurship Competition
Matwings Technology Founded, Launched Independent R&D of General AI for Protein Design
16th Floor, Building 1, No. 58 Yuanmei Road, Minhang District, Shanghai, China
